An open label trial of anakinra to prevent respiratory failure in COVID-19.
eLife
View this publicationeLife
View this publicationScience advances
View this publicationData in brief
View this publicationAnnual review of immunology
View this publicationMed (New York, N.Y.)
View this publicationSTAR protocols
View this publicationJournal of leukocyte biology
View this publicationJournal of neuroinflammation
View this publicationClinical & translational immunology
View this publicationThe Lancet. Infectious diseases
View this publication